Accueil   Diary - News   All news MaaT Pharma announces CE marking for its globally unique medical device

MaaT Pharma announces CE marking for its globally unique medical device

Lyon (France), June 15, 2017. A few days aftersigning a strategic partnership for the treatment of intestinal dysbiosis by FMT (Fecal Microbiota Transfer), MaaT Pharma pursues its industrialization process with the CE marking of the first ever stool collection and dilution device.

 

Quality, safety and reproducibility: more than a medical device, a technological breakthrough in the field of FMT

 

The necessary standardization of a booming activity requiring challenging safety rules ... The international protocols established by teams who practice FMT vary according to the indications treated and are intended to minimize the risk of transmission of pathogens.

 

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree